These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Long-term oncologic outcomes of hand-assisted laparoscopic radical nephrectomy for clinically localized renal cell carcinoma: a multi-institutional comparative study. Park YH; Lee ES; Kim HH; Kwak C; Ku JH; Lee SE; Byun SS; Hong SK; Kim YJ; Kang SH; Hong SH J Laparoendosc Adv Surg Tech A; 2014 Aug; 24(8):556-62. PubMed ID: 25007232 [TBL] [Abstract][Full Text] [Related]
32. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276 [TBL] [Abstract][Full Text] [Related]
33. Renal fossa recurrence after radical nephrectomy: Current management, and oncological outcomes. Romeo A; Garcia Marchiñena P; Jurado AM; Gueglio G Urol Oncol; 2020 Feb; 38(2):42.e7-42.e12. PubMed ID: 31711833 [TBL] [Abstract][Full Text] [Related]
34. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome. Krejci KG; Blute ML; Cheville JC; Sebo TJ; Lohse CM; Zincke H Urology; 2003 Oct; 62(4):641-6. PubMed ID: 14550434 [TBL] [Abstract][Full Text] [Related]
35. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice. Bedke J; Heide J; Ribback S; Rausch S; de Martino M; Scharpf M; Haitel A; Zimmermann U; Pechoel M; Alkhayyat H; Shariat SF; Dombrowski F; Stenzl A; Burchardt M; Klatte T; Kroeger N BJU Int; 2018 Jan; 121(1):84-92. PubMed ID: 28803448 [TBL] [Abstract][Full Text] [Related]
36. [The local recurrence of renal-cell carcinoma after nephron-sparing surgery]. Iliukhin IuA; Shchukin DV Voen Med Zh; 2005 Feb; 326(2):32-7, 80. PubMed ID: 15822775 [TBL] [Abstract][Full Text] [Related]
37. Cytokine therapy response as a selection criterion for cytoreductive nephrectomy in metastatic renal clear-cell carcinoma of intermediate prognosis. Results and conclusions from a combined analysis. Bex A; Haanen JB; Vyth-Dreese FA; Horenblas S; de Gast GC Urol Int; 2008; 80(4):367-71. PubMed ID: 18587246 [TBL] [Abstract][Full Text] [Related]
38. Laparoscopic radical nephrectomy vs laparoscopic or open partial nephrectomy for T1 renal cell carcinoma: comparison of complication rates in elderly patients during the initial phase of adoption. Becker A; Ravi P; Roghmann F; Trinh QD; Tian Z; Larouche A; Kim S; Shariat SF; Kluth L; Dahlem R; Fisch M; Graefen M; Eichelberg C; Karakiewicz PI; Sun M Urology; 2014 Jun; 83(6):1285-91. PubMed ID: 24862392 [TBL] [Abstract][Full Text] [Related]
39. Clinical impact of segmental renal vein invasion on recurrence in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy. Yoshida T; Ohe C; Tsuzuki T; Sugi M; Kinoshita H; Tsuta K; Matsuda T Int J Clin Oncol; 2020 Mar; 25(3):464-471. PubMed ID: 31531786 [TBL] [Abstract][Full Text] [Related]